Jen-Der Lin相关文献与解析，生知库 | 链接生命科学的每一步

Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery

细针抽吸囊液蛋白质组、癌细胞分泌组和公共转录组数据集的综合分析，以发现乳头状甲状腺癌的生物标志物

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.23951

Chia-Chun Wu, Jen-Der Lin, Jeng-Ting Chen, Chih-Min Chang, Hsiao-Fen Weng, Chuen Hsueh, Hui-Ping Chien, Jau-Song Yu

A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer

细胞周期依赖性蛋白激酶抑制剂 dinaciclib 在甲状腺癌临床前治疗模型中的应用

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0172315

Shu-Fu Lin, Jen-Der Lin, Chuen Hsueh, Ting-Chao Chou, Richard J Wong

Higher body weight and distant metastasis are associated with higher radiation exposure to the household environment from patients with thyroid cancer after radioactive iodine therapy

接受放射性碘治疗后，甲状腺癌患者体重增加和远处转移与家庭环境辐射暴露增加有关

期刊:Medicine

影响因子:

doi:10.1097/MD.0000000000007942

Sheng-Fong Kuo, Tsung-Ying Ho, Miaw-Jene Liou, Kun-Ju Lin, Ru-Chin Cheng, Sheng-Chieh Chan, Bie-Yui Huang, Soh-Ching Ng, Feng-Hsuan Liu, Hung-Yu Chang, Sheng-Hwu Hsieh, Kun-Chun Chiang, Huang-Yang Chen, Ta-You Lo, Chih-Lang Lin, Jen-Der Lin

Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models

HSP90 抑制剂 ganetespib 对临床前甲状腺癌模型的疗效

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.17180

Shu-Fu Lin, Jen-Der Lin, Chuen Hsueh, Ting-Chao Chou, Chun-Nan Yeh, Ming-Huang Chen, Richard J Wong

Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment

组蛋白去乙酰化酶抑制剂 (PXD101) 对甲状腺癌治疗的效用

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0077684

Shu-Fu Lin, Jen-Der Lin, Ting-Chao Chou, Yu-Yao Huang, Richard J Wong

Targeting PLKs as a therapeutic approach to well-differentiated thyroid cancer

以 PLK 为靶点治疗分化良好的甲状腺癌

Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery

细针抽吸囊液蛋白质组、癌细胞分泌组和公共转录组数据集的综合分析，以发现乳头状甲状腺癌的生物标志物

A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer

细胞周期依赖性蛋白激酶抑制剂 dinaciclib 在甲状腺癌临床前治疗模型中的应用

Higher body weight and distant metastasis are associated with higher radiation exposure to the household environment from patients with thyroid cancer after radioactive iodine therapy

接受放射性碘治疗后，甲状腺癌患者体重增加和远处转移与家庭环境辐射暴露增加有关

Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models

HSP90 抑制剂 ganetespib 对临床前甲状腺癌模型的疗效

Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment

组蛋白去乙酰化酶抑制剂 (PXD101) 对甲状腺癌治疗的效用